X
Log In
Username or E-mail:
Password:
EULA
Log In
Forgot Password
Sign Up
Sign Up
Username:
E-mail:
Password:
EULA
Sign Up
Forgot Password
Already a Member
Username or E-mail
Send Forgot Mail
Back to Login
EULA
X
Share This!
Sign Up
Log In
Logout
X
English Türkçe

NVAX

Closed

Novavax Inc

6.61
+0.31 (+4.92%)
Last Update: 01 Jul 2025 23:20:00
Yesterday: 6.3
Day's Range: 6.23 - 6.81
Send
When Written:
 
8.46
Novavax Inc. is a biotechnology company that focuses on the development of vaccines for infectious diseases. The company was founded in 1987 and is headquartered in Gaithersburg, Maryland. Novavax has a proprietary technology platform called Matrix-M, which is designed to enhance the immune response to vaccines. The company's pipeline includes vaccines for respiratory syncytial virus (RSV), influenza, Ebola, and COVID-19. Novavax has partnerships with several organizations, including the Coalition for Epidemic Preparedness Innovations (CEPI) and the Bill and Melinda Gates Foundation. The company's COVID-19 vaccine candidate, NVX-CoV2373, has shown promising results in clinical trials and has received emergency use authorization in several countries.

Note: This message is generated by artificial intelligence; it does not guarantee the accuracy of the information it contains and should not be considered as investment advice.
(0)
(0)
Send
Contact with us

Mail:
Message:
Cancel
Send
IP Adresiniz:216.73.216.58
X